Inclusion of omalizumab in a trastuzumab desensitization protocol Ester María Barreiro-Fernández; Manuel David Gil-Sierra; María del Pilar Briceño-Casado; Carmen Martínez-Díaz; Esmeralda Ríos-Sánchez;

Classification of antineoplastic drug-induced tissue damage: a Consensus of the Spanish Oncology Pharmacy Group Asunción Albert-Marí; M.a Ángeles Gil-Lemus; David Conde-Estévez; Begoña San José-Ruiz; Inmaculada Jiménez-Pulido; M.a Jesús Esteban-Mensua; Ana Cristina Cercós-Lletí; M.a Sacramento Díaz-Carrasco;